Rapid Adoption of Precision Technologies in Molecular Diagnostics and Life Sciences Drives Market Growth
The global market for digital PCR (dPCR) and quantitative PCR (qPCR) is projected to reach $14.8 billion by 2029, according to a comprehensive report released today. This significant growth is being driven by innovations in precision molecular diagnostics, expanding applications in life sciences research, and increased demand for advanced testing solutions across various industries.
The report highlights the expanding role of dPCR and qPCR technologies in detecting and quantifying nucleic acids, providing highly accurate and reproducible results for diagnostic and research applications. Key sectors benefiting from these technologies include healthcare, pharmaceuticals, biotechnology, and agriculture, among others.
Key Market Drivers:
Advances in Molecular Diagnostics: With the rise in genetic diseases, infectious diseases, and cancer, healthcare professionals increasingly rely on dPCR and qPCR technologies for early diagnosis and personalized treatment.
COVID-19 Pandemic Impact: The pandemic accelerated the global adoption of qPCR for virus detection, contributing to the surge in demand for these technologies. This trend is expected to continue as new virus variants and future outbreaks are anticipated.
Growing Research and Development in Genomics: Expanding research into genomics, proteomics, and molecular biology continues to fuel the adoption of dPCR and qPCR in laboratories and academic institutions.
Key Players in the Market: Major companies driving innovation in this space include Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen, and Roche, among others. These players are investing in R&D to introduce novel products that improve accuracy, sensitivity, and efficiency in PCR processes.
Emerging Technologies and Opportunities:
Microfluidics Integration: The development of microfluidics-based dPCR platforms is expected to revolutionize the field, offering increased throughput and scalability, making it more accessible for routine diagnostics.
Non-Invasive Prenatal Testing (NIPT): With the rise of NIPT, qPCR and dPCR are playing critical roles in screening for genetic disorders in fetuses, presenting a major growth opportunity in the reproductive health sector.
Point-of-Care Testing: Portable and rapid PCR devices are being developed for point-of-care testing, expanding the reach of molecular diagnostics to decentralized settings, including remote areas and urgent care facilities.
Market Forecast: By 2029, the global dPCR and qPCR market is expected to reach $14.8 billion, growing at a compound annual growth rate (CAGR) of 8.1% from 2024 to 2029. North America currently leads the market, followed by Europe and the Asia-Pacific region, which is expected to witness the highest growth due to increasing investments in healthcare infrastructure and R&D activities.
About the Report: The comprehensive report, titled "Global dPCR and qPCR Market 2024-2029", provides an in-depth analysis of market dynamics, emerging trends, competitive landscape, and growth opportunities. The report covers market segmentation by product type, end-user, application, and region, offering valuable insights for stakeholders in the industry.
Content Source:
https://www.marketsandmarkets.com/PressReleases/digital-pcr.asp
https://www.marketsandmarkets.com/ResearchInsight/digital-pcr-market.asp
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Comments
0 comment